Futures surged early Thursday as a federal court knocked down President Donald Trump’s “reciprocal” tariffs. Solid earnings from artificial intelligence heavyweight Nvidia also buoyed the market. Fu… [+2211 chars]Read More
Eli Lillys nextgeneration obesity drug retatrutide clears first latestage diabetes trial CNBC
Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill, orforglipron.
